Rolph Timothy Insider Trading Activity
Rolph Timothy has been net-selling over the last 12 months with 0 purchases and 7 sales across 1 company.
AKRO is the most-traded position with 7 trades. The largest single transaction was a sale of AKRO for $551K on Sep 8, 2025.
Performance Scorecard
Forward stock performance after each transaction by Rolph Timothy. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -1.8% | 47% | 15 |
| 90 days | — | +4.8% | 67% | 12 |
| 120 days | — | +2.6% | 50% | 10 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersAKRO · Akero Therapeutics, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Rolph Timothy bought and sold AKRO.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Oct 7, 2025 | AKRO | Sell | 11,463 | $46.01 | $527K | −6.4% | Chief Scientific Officer | |
Oct 7, 2025 | AKRO | Sell | 1,037 | $46.82 | $49K | −0.6% | Chief Scientific Officer | |
Sep 11, 2025 | AKRO | Sell | 553 | $43.02 | $24K | −0.3% | Chief Scientific Officer | |
Sep 8, 2025 | AKRO | Sell | 12,466 | $44.17 | $551K | −6.9% | Chief Scientific Officer | |
Sep 8, 2025 | AKRO | Sell | 34 | $44.88 | $2K | −0.0% | Chief Scientific Officer | |
Aug 5, 2025 | AKRO | Sell | 5,538 | $49.06 | $272K | −3.1% | Chief Scientific Officer | |
Aug 5, 2025 | AKRO | Sell | 6,962 | $49.49 | $345K | −4.0% | Chief Scientific Officer | |
Jul 7, 2025 | AKRO | Sell | 10,634 | $50.93 | $542K | −5.9% | Chief Scientific Officer | |
Jul 7, 2025 | AKRO | Sell | 1,825 | $52.00 | $95K | −1.1% | Chief Scientific Officer | |
Jul 7, 2025 | AKRO | Sell | 41 | $52.62 | $2K | −0.0% | Chief Scientific Officer | |
Jun 18, 2025 | AKRO | Sell | 1,129 | $54.84 | $62K | −0.7% | Chief Scientific Officer | |
Jun 10, 2025 | AKRO | Sell | 2,358 | $54.00 | $127K | −1.4% | Chief Scientific Officer | |
Jun 6, 2025 | AKRO | Sell | 25,000 | $55.04 | $1.4M | −12.8% | Chief Scientific Officer | |
Jun 5, 2025 | AKRO | Sell | 9,350 | $53.37 | $499K | −5.1% | Chief Scientific Officer | |
Jun 5, 2025 | AKRO | Sell | 3,150 | $53.84 | $170K | −1.8% | Chief Scientific Officer |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| AKRO | Akero Therapeutics, Inc. | 15 | $4.6M |
Other insiders at Akero Therapeutics, Inc.
5 other tracked filers at AKRO.